Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sarah Aljohani PharmD"'
Autor:
Amer Alzahrani MD RRT, Hadeel Alkofide Ph.D., Hala Joharji PharmD, Ghazwa B. Korayem PharmD, Sarah Aljohani PharmD, Hanan Alshareef PharmD, Mashael AlFaifi PharmD, Hassan Alalawi MBBS, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Objectives Bleeding remains a common complication post-thoracic surgery. Although intravenous tranexamic acid (TXA) has been shown to decrease blood loss, its use has been associated with adverse effects. Accordingly, topical TXA has been proposed as
Externí odkaz:
https://doaj.org/article/0c5594ece7524430b9752cd80aa94f80
Autor:
Awatif Hafiz PharmD, BCCP, Hadeel Alkofide PhD, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Hala Joharji PharmD, BCPS, BCMTM, Sarah Aljohani PharmD, BCPS, Khadijah A. Sarkhi PharmD, Reem Alharbi PharmD, Ghazwa B. Korayem PharmD, BCPS, Mashael AlFaifi PharmD, BCPS, Samiah Alsohimi PharmD, Ohoud Aljuhani PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
The prevalence of venous thromboembolism is high in patients with COVID-19, despite prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis regimen in non-critically ill patients with mild to moderate COVID-19 is sti
Externí odkaz:
https://doaj.org/article/ef4a26e56ccb4240bf800fe922df2a42